Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.

-HR 466 - Amateur Radio Parity Act - all provisions related to cable. -HR 583 - Preventing Illegal Radio Abuse Through Enforcement (PIRATE) Act - all provisions related to cable. -HR 896 - Fairness in Political Advertising Act of 2019 - all provisions related to cable. -HR 1789 - Local and Independent Television Protection Act - all provisions related to cable. -HR 1848 - Communications Jobs Training Act of 2019 - all provisions related to cable. -HR 2135 - Preventing Adversaries Internationally from Disbursing Advertising Dollars (PAID AD) Act - all provisions related to cable. -HR 2592 - Honest Ads Act - all provisions related to cable. -HR 2682 - Agricultural News and Rural Content Act of 2019 - all provisions related to cable. -HR 2860 - Bots Research Act - all provisions related to cable. -HR 3002 - To provide for the carriage of certain television broadcast stations - all provisions related to cable. -HR 3393 - To amend the Communications Act of 1934 to prohibit Federal funding for the Corporation for Public Broadcasting after fiscal year 2021 - all provisions related to cable. -HR 3994 - Modern Television Act of 2019 - all provisions related to cable. -HR 4054 - Stand by Every Ad Act - all provisions related to cable. -HR 4106 - Responsibility in Drug Advertising Act of 2019 - all provisions related to cable. -HR 5015 - Honest Campaigns Act of 2019 - all provisions related to cable. -HR 5016 - Fair and Clear Campaign Transparency Act - all provisions related to cable. -HR 5025 - Western Expanded In-State Television (WEST) Access Act of 2019 - all provisions related to cable. -HR 5035 - Television Viewer Protection Act of 2019 - all provisions related to cable. -HR 5140 - Satellite Television Community Protection and Promotion Act of 2019 - all provisions related to cable. -HR 5263 - Stopping Grinch Bots Act of 2019 - all provisions related to cable. -HR 5365 - License Transfer Modernization Act of 2019 - all provisions related to cable. -HR 5564 - Enhancing Broadcaster Diversity and Inclusion by Verifying and Ensuring the Reporting required by Statute is Transpiring and Yielding (DIVERSITY) Data Act - all provisions related to cable. -HR 5567 - Measuring the Economics Driving Investments and Access (MEDIA) for Diversity Act of 2020 - all provisions related to cable. -HR 5659 - Protecting Community Television Act - all provisions related to cable. -HR 5894 - Transparency in Prescription Drug Advertising Act - all provisions related to cable. -HRes 549 - Reaffirming the commitment to media diversity and pledging to work with media entities and diverse stakeholders to develop common ground solutions to eliminate barriers to media diversity - all provisions related to cable. -HConRes 20 - Supporting the Local Radio Freedom Act - all provisions related to cable. -HConRes 55 - Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements - all provisions related to cable. -S 189 - Social Media Privacy Protection and Consumer Rights Act of 2019 - all provisions related to cable. -S 822 - To permit the televising of Supreme Court proceedings - all provisions related to cable. -S 941 - Section 331 Obligation Clarification Act - all provisions related to cable. -S 1228 - Preventing Illegal Radio Abuse Through Enforcement (PIRATE) Act - all provisions related to cable. -S 1356 - Honest Ads Act - all provisions related to cable. -S 1748 - Furthering Access and Networks for Sports Act - all provisions related to cable. -S 1962 - Preventing Adversaries Internationally from Disbursing Advertising Dollars (PAID AD) Act - all provisions related to cable. -S 2125 - Bot Disclosure and Accountability Act of 2019 - all provisions related to cable. -S 2181 - Cyber AIR Act - all provisions related to cable. -S 2182 - Security and Privacy in Your Car (SPY Car) Act of 2019 - all provisions related to cable. -S 2454 - Go Pack Go Act of 2019 - all provisions related to cable. -S 2763 - Filter Bubble Transparency Act - all provisions related to cable. -S 2789 - Satellite Television Access Reauthorization (STAR) Act - all provisions related to cable. -S 2829 - Western Expanded In-State Television (WEST) Access Act of 2019 - all provisions related to cable. -S 2957 - Stopping Grinch Bots Act of 2019 - all provisions related to cable. -S 3180 - Responsibility in Drug Advertising Act of 2020 - all provisions related to cable. -S 3218 - Protecting Community Television Act - all provisions related to cable. -S 3473 - Airline Information and Entertainment Access Act - all provisions related to cable. -SRes 306 - Reaffirming the commitment to media diversity and pledging to work with media entities and diverse stakeholders to develop common ground solutions to eliminate barriers to media diversity - all provisions related to cable.

Client expense: $3,540,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE

H.Con.Res.55: Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements. H.R. 4106: Responsibility in Drug Advertising Act of 2019 H.R. 5894: Transparency in Prescription Drug Advertising Act S. 73: End Taxpayer Subsidies for Drug Ads Act S. 3180: Responsibility in Drug Advertising Act of 2020

Client expense: $738,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Library of Congress (LOC), Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Immigration & Customs Enforcement (ICE), U.S. Trade Representative (USTR)

S. 61, Safe and Affordable Drugs from Canada Act (Grassley) - drug importation S. 64, Preserve Access to Affordable Generics and Biosimilars Act (Grassley-Klobuchar) - prohibiting pay-for-delay settlements S. 73, End Taxpayer Subsidies for Drug Ads Act (Shaheen) - prohibiting tax deduction for DTC advertising expenses S. 102, Prescription Drug Price Relief Act (Sanders) - reforms linked to international pricing S. 340, CREATES Act (Leahy) - removing barriers to generic drugs S. 344, Hatch-Waxman Integrity Act (Tillis) - inter partes review process S. 366, FLAT Prices Act (Durbin) - reforms for drugs with sudden price spikes S. 378, Stop Price Gouging Act (Durbin) - excise tax for drugs that have price spikes S. 440, Preserving Access to Cost-Effective Drugs Act (Cotton) - sovereign immunity and Inter Partes Review process S. 474, SPIKE Act (Wyden) - justification for drug price increases S. 476, Creating Transparency to Have Drug Rebates Unlocked Act (Wyden) - drug price transparency S. 637, CURE High Drug Prices Act (Blumenthal) - remedies for price gouging S. 657, Point of Sale Rebates (Braun) S. 659, Biologic Patent Transparency Act (Collins) - patent disclosure requirements S. 660, Efficiency and Transparency in Petitions Act (Braun) - FDA citizen petition process S. 844, Short on Competition Act (Klobuchar) - remedies for marginally competitive drug markets S. 977, Transparency Drug Pricing Act (Scott) - transparency and drug pricing reforms S. 1209, Reforming Evergreening and Manipulation that Extends Drug Years Act (Cassidy) - preventing evergreening of patent protections S. 1224, Stop STALLING Act (Klobuchar) - citizen petition process S. 1227, Prescription Pricing for the People Act (Grassley) - FTC report on role of PBMs and allegations of anticompetitive conduct by manufacturers of sole-source drugs S. 1384, Prescription Drug Rebate Reform Act (Romney-Braun) - prescription drug cost sharing S. 1416, Affordable Prescriptions for Patients Act (Cornyn) - product hopping, patent thickets S. 1664, Prescription Drug Price Reporting Act (Scott) - prescription drug price reporting S. 2247, Phair Relief Act of 2019 (Kennedy)-transparency around price concessions for drugs S. 2387, We Protect American Investment in Drugs Act (Van Hollen)-drug pricing S. 2543, Prescription Drug Pricing Reduction Act of 2019 (Grassley)-Drug pricing S. 2740, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 (Isakson) - regulations re nonprescription drugs that are marketed without an approved new drug application S. 3052, United States-Mexico-Canada Agreement Implementation Act (Grassley) - drug pricing S. 3067, Non-Opioids Prevent Addiction In the Nation Act (Capito) - non-opioid treatments S. 3092, Expanding Access to Low-Cost Generics Act of 2019 (Smith) - exclusivity period H.R. 3, Lower Drug Costs Now Act of 2019 (Pallone)-drug pricing H.R. 465, Prescription Drug Price Relief Act (Khanna) - reforms linked to international pricing H.R. 478, Safe and Affordable Drugs from Canada Act (Pingree) - drug importation H.R. 938, BLOCKING Act (Schrader) - changes to 180-day period of market exclusivity for first generic applicant H.R. 965, CREATES Act (Cicilline) - removing barriers to generic drugs H.R. 985, FAST Generics Act (Welch) - removing barriers to generic drugs H.R. 990, Hatch-Waxman Integrity Act (Flores) - inter partes review process H.R. 1093, Stop Price Gouging Act (Pocan) - excise tax for drugs that have price spikes H.R. 1188, FLAT Prices Act (Golden) - reforms for drugs with sudden price spikes H.R. 1344, Competitive DRUGS Act (Doggett) - prohibiting pay-for-delay agreements H.R. 1419, Public Option Deficit Reduction Act (DeFazio) - public option H.R. 1499, Protecting Consumer Access to Generic Drugs Act (Rush) - prohibiting pay-for-delay agreements H.R. 1503, Orange Book Transparency Act (Kelly) - removal of invalidated patents from Orange Book H.R. 1506, FAIR Generics Act (Barragan) - changes to 180-day period of market exclusivity for first generic applicant H.R. 1520, Purple Book Continuity Act (Eshoo) - access to updated information on biologics and biosimilars H.R. 2038, State-Based, Market-Oriented Prescription Drug Negotiations Act (Meadows) - drug price negotiations H.R. 2064, Sunshine for Samples Act (Chu) - reporting requirements on drug samples H.R. 2069, SPIKE Act (Horsford) -justification for drug price increases H.R. 2087, Drug Price Transparency Act (Doggett) - reporting of drug pricing data under Medicare Part B H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (Neal) - transparency in drug pricing H.R. 2115, Public Disclosure of Drug Discounts Act (Spanberger) - disclosure of negotiated Rx discounts H.R. 2279, Safe Step Act (Ruiz) - exceptions process for medication step therapy H.R. 2296, FAIR Drug Pricing Act (Schakowsky) - transparency requirements and justification for high list prices and drug price increases H.R. 2374, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (Jeffries) - citizen petition process H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act (Nadler) - prohibiting pay-for-delay agreements H.R. 2376, Prescription Pricing for the People Act (Collins) - FTC study on role of PBMs and competition and transparency in pharmaceutical supply chain H.R. 3379, Price Relief, Innovation, and Competition for Essential Drugs Act (Schakowsky) - exclusivity period for biological products H.R. 3805, Prescription Drug Rebate Reform Act of 2019 (Gallagher)- drug rebates H.R. 3927, PDMPs Help Patients Act of 2019 (McKinley)-integrating SUDs and behavioral health into PDMPs H.R. 3947, Competition Prescription Act of 2019 (Meadows)- drug pricing H.R. 4010, Emergency Access to Insulin Act of 2019 (Craig)- drug pricing H.R. 4106, Responsibility in Drug Advertising Act of 2019 (DeLauro)-transparency in drug pricing H.R. 4244, MAGIC Act (Kelly)-pathways for insulin approval H.R. 4398, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (Cicilline)-drug pricing H.R. 4455, BIOSIM Act (Schrader)-access to biosimilars H.R. 4460, Turn the Tide Act (Kuster)-Opioids H.R. 4538, Closing Loopholes for Orphan Drugs Act (Welch)-Access to drugs H.R. 4640, Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019 (DeFazio) - direct negotiation H.R. 4712, Fairness in Orphan Drug Exclusivity Act (Dean) - limitations on exclusive approval of orphan drugs H.R. 4810, Opioid Prescription Verification Act of 2019 (David) - dispensing of controlled substances H.R. 4906, Insulin Price Reduction Act (Diana DeGette) - insulin costs H.R. 5304, PBM Transparency in Prescription Drug Costs Act (Schrader) - PBMs H.R. 5364, End Price Gouging for Insulin Act (Beatty) - annual reference price for insulin products H.R. 5430, United States-Mexico-Canada Agreement Implementation Act (Hoyer) - drug pricing H.R. 5442, Lowest Price for Patients Act (Porter) - pharmacies to disclose any differential between the cost of a prescription drug H.R. 5444, Lower Insulin Costs Now Act (Underwood) - lowering insulin costs H.Con.Res. 55, Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements. (Burgess)-drug pricing Regulatory Issues: Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to price of drugs and biologics and proposals to limit high prices; issues related to drug patents and market exclusivity; issues related to pharmacy benefit managers; issues related to biosimilars; issues related to approval of drugs and biologics; issues relating to opioids; issues relating to prescription drug rebates; issues relating to prescription drug price blueprint; direct-to-consumer advertising for prescription drugs; issues related to proposed changes to removal of safe harbor protection for rebates (proposed rule); issues relating to access for investigational drugs; and other issues relating to health care reform implementation.

-HR 466 - Amateur Radio Parity Act - all provisions related to cable. -HR 583 - Preventing Illegal Radio Abuse Through Enforcement (PIRATE) Act - all provisions related to cable. -HR 896 - Fairness in Political Advertising Act of 2019 - all provisions related to cable. -HR 1789 - Local and Independent Television Protection Act - all provisions related to cable. -HR 1848 - Communications Jobs Training Act of 2019 - all provisions related to cable. -HR 2135 - Preventing Adversaries Internationally from Disbursing Advertising Dollars (PAID AD) Act - all provisions related to cable. -HR 2592 - Honest Ads Act - all provisions related to cable. -HR 2682 - Agricultural News and Rural Content Act of 2019 - all provisions related to cable. -HR 2860 - Bots Research Act - all provisions related to cable. -HR 3002 - To provide for the carriage of certain television broadcast stations - all provisions related to cable. -HR 3393 - To amend the Communications Act of 1934 to prohibit Federal funding for the Corporation for Public Broadcasting after fiscal year 2021 - all provisions related to cable. -HR 3994 - Modern Television Act of 2019 - all provisions related to cable. -HR 4054 - Stand by Every Ad Act - all provisions related to cable. -HR 4106 - Responsibility in Drug Advertising Act of 2019 - all provisions related to cable. -HR 5015 - Honest Campaigns Act of 2019 - all provisions related to cable. -HR 5016 - Fair and Clear Campaign Transparency Act - all provisions related to cable. -HR 5025 - Western Expanded In-State Television (WEST) Access Act of 2019 - all provisions related to cable. -HR 5035 - Television Viewer Protection Act of 2019 - all provisions related to cable. -HR 5140 - Satellite Television Community Protection and Promotion Act of 2019 - all provisions related to cable. -HR 5263 - Stopping Grinch Bots Act of 2019 - all provisions related to cable. -HR 5365 - License Transfer Modernization Act of 2019 - all provisions related to cable. -HRes 549 - Reaffirming the commitment to media diversity and pledging to work with media entities and diverse stakeholders to develop common ground solutions to eliminate barriers to media diversity - all provisions related to cable. -HConRes 20 - Supporting the Local Radio Freedom Act - all provisions related to cable. -HConRes 55 - Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements - all provisions related to cable. -S 189 - Social Media Privacy Protection and Consumer Rights Act of 2019 - all provisions related to cable. -S 822 - To permit the televising of Supreme Court proceedings - all provisions related to cable. -S 941 - Section 331 Obligation Clarification Act - all provisions related to cable. -S 1228 - Preventing Illegal Radio Abuse Through Enforcement (PIRATE) Act - all provisions related to cable. -S 1356 - Honest Ads Act - all provisions related to cable. -S 1748 - Furthering Access and Networks for Sports Act - all provisions related to cable. -S 1962 - Preventing Adversaries Internationally from Disbursing Advertising Dollars (PAID AD) Act - all provisions related to cable. -S 2125 - Bot Disclosure and Accountability Act of 2019 - all provisions related to cable. -S 2181 - Cyber AIR Act - all provisions related to cable. -S 2182 - Security and Privacy in Your Car (SPY Car) Act of 2019 - all provisions related to cable. -S 2454 - Go Pack Go Act of 2019 - all provisions related to cable. -S 2763 - Filter Bubble Transparency Act - all provisions related to cable. -S 2789 - Satellite Television Access Reauthorization (STAR) Act - all provisions related to cable. -S 2829 - Western Expanded In-State Television (WEST) Access Act of 2019 - all provisions related to cable. -S 2957 - Stopping Grinch Bots Act of 2019 - all provisions related to cable. -SRes 306 - Reaffirming the commitment to media diversity and pledging to work with media entities and diverse stakeholders to develop common ground solutions to eliminate barriers to media diversity - all provisions related to cable.

H.R.2135,"Preventing Adversaries Internationally from Disbursing Advertising Dollars Act or the PAID AD Act," all provisions H.R.2592, Honest Ads Act, all provisions H.R.3327, Drug Price Transparency for Medicare Patients Act of 2019, all provisions H.R.4054,Stand By Every Ad Act, all provisions HR 4106, Responsibility in Drug Advertising Act of 2019, all provisions H.Con.Res.55, Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements, all provisions S.73, "End Taxpayer Subsidies for Drug Ads Act, all provisions related to advertising S.474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019," all provisions related to advertising S.1356, Honest Ads Act, all provisions S.1437, Drug-price Transparency in Communications (DTC) Act, all provisions

Client expense: $900,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

S. 61, Safe and Affordable Drugs from Canada Act (Grassley) - drug importation S. 64, Preserve Access to Affordable Generics and Biosimilars Act (Grassley-Klobuchar) - prohibiting pay-for-delay settlements S. 73, End Taxpayer Subsidies for Drug Ads Act (Shaheen) - prohibiting tax deduction for DTC advertising expenses S. 102, Prescription Drug Price Relief Act (Sanders) - reforms linked to international pricing S. 340, CREATES Act (Leahy) - removing barriers to generic drugs S. 344, Hatch-Waxman Integrity Act (Tillis) - inter partes review process S. 366, FLAT Prices Act (Durbin) - reforms for drugs with sudden price spikes S. 378, Stop Price Gouging Act (Durbin) - excise tax for drugs that have price spikes S. 440, Preserving Access to Cost-Effective Drugs Act (Cotton) - sovereign immunity and Inter Partes Review process S. 474, SPIKE Act (Wyden) - justification for drug price increases S. 476, Creating Transparency to Have Drug Rebates Unlocked Act (Wyden) - drug price transparency S. 637, CURE High Drug Prices Act (Blumenthal) - remedies for price gouging S. 657, Point of Sale Rebates (Braun) S. 659, Biologic Patent Transparency Act (Collins) - patent disclosure requirements S. 660, Efficiency and Transparency in Petitions Act (Braun) - FDA citizen petition process S. 844, Short on Competition Act (Klobuchar) - remedies for marginally competitive drug markets S. 977, Transparency Drug Pricing Act (Scott) - transparency and drug pricing reforms S. 1209, Reforming Evergreening and Manipulation that Extends Drug Years Act (Cassidy) - preventing evergreening of patent protections S. 1224, Stop STALLING Act (Klobuchar) - citizen petition process S. 1227, Prescription Pricing for the People Act (Grassley) - FTC report on role of PBMs and allegations of anticompetitive conduct by manufacturers of sole-source drugs S. 1384, Prescription Drug Rebate Reform Act (Romney-Braun) - prescription drug cost sharing S. 1416, Affordable Prescriptions for Patients Act (Cornyn) - product hopping, patent thickets S. 1664, Prescription Drug Price Reporting Act (Scott) - prescription drug price reporting S. 2247, Phair Relief Act of 2019 (Kennedy)-transparency around price concessions for drugs S. 2387, We Protect American Investment in Drugs Act (Van Hollen)-drug pricing S. 2543, Prescription Drug Pricing Reduction Act of 2019 (Grassley)-Drug pricing H.R. 3, Lower Drug Costs Now Act of 2019 (Pallone)-drug pricing H.R. 465, Prescription Drug Price Relief Act (Khanna) - reforms linked to international pricing H.R. 478, Safe and Affordable Drugs from Canada Act (Pingree) - drug importation H.R. 938, BLOCKING Act (Schrader) - changes to 180-day period of market exclusivity for first generic applicant H.R. 965, CREATES Act (Cicilline) - removing barriers to generic drugs H.R. 985, FAST Generics Act (Welch) - removing barriers to generic drugs H.R. 990, Hatch-Waxman Integrity Act (Flores) - inter partes review process H.R. 1093, Stop Price Gouging Act (Pocan) - excise tax for drugs that have price spikes H.R. 1188, FLAT Prices Act (Golden) - reforms for drugs with sudden price spikes H.R. 1344, Competitive DRUGS Act (Doggett) - prohibiting pay-for-delay agreements H.R. 1419, Public Option Deficit Reduction Act (DeFazio) - public option H.R. 1499, Protecting Consumer Access to Generic Drugs Act (Rush) - prohibiting pay-for-delay agreements H.R. 1503, Orange Book Transparency Act (Kelly) - removal of invalidated patents from Orange Book H.R. 1506, FAIR Generics Act (Barragan) - changes to 180-day period of market exclusivity for first generic applicant H.R. 1520, Purple Book Continuity Act (Eshoo) - access to updated information on biologics and biosimilars H.R. 2038, State-Based, Market-Oriented Prescription Drug Negotiations Act (Meadows) - drug price negotiations H.R. 2064, Sunshine for Samples Act (Chu) - reporting requirements on drug samples H.R. 2069, SPIKE Act (Horsford) -justification for drug price increases H.R. 2087, Drug Price Transparency Act (Doggett) - reporting of drug pricing data under Medicare Part B H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (Neal) - transparency in drug pricing H.R. 2115, Public Disclosure of Drug Discounts Act (Spanberger) - disclosure of negotiated Rx discounts H.R. 2279, Safe Step Act (Ruiz) - exceptions process for medication step therapy H.R. 2296, FAIR Drug Pricing Act (Schakowsky) - transparency requirements and justification for high list prices and drug price increases H.R. 2374, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (Jeffries) - citizen petition process H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act (Nadler) - prohibiting pay-for-delay agreements H.R. 2376, Prescription Pricing for the People Act (Collins) - FTC study on role of PBMs and competition and transparency in pharmaceutical supply chain H.R. 3379, Price Relief, Innovation, and Competition for Essential Drugs Act (Schakowsky) - exclusivity period for biological products H.R. 3805, Prescription Drug Rebate Reform Act of 2019 (Gallagher)- drug rebates H.R. 3927, PDMPs Help Patients Act of 2019 (McKinley)-integrating SUDs and behavioral health into PDMPs H.R. 3947, Competition Prescription Act of 2019 (Meadows)- drug pricing H.R. 4010, Emergency Access to Insulin Act of 2019 (Craig)- drug pricing H.R. 4106, Responsibility in Drug Advertising Act of 2019 (DeLauro)-transparency in drug pricing H.R. 4244, MAGIC Act (Kelly)-pathways for insulin approval H.R. 4398, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (Cicilline)-drug pricing H.R. 4455, BIOSIM Act (Schrader)-access to biosimilars H.R. 4460, Turn the Tide Act (Kuster)-Opioids H.R. 4538, Closing Loopholes for Orphan Drugs Act (Welch)-Access to drugs H.Con.Res. 55, Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements. (Burgess)-drug pricing Regulatory Issues: Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to price of drugs and biologics and proposals to limit high prices; issues related to drug patents and market exclusivity; issues related to pharmacy benefit managers; issues related to biosimilars; issues related to approval of drugs and biologics; issues relating to opioids; issues relating to prescription drug rebates; issues relating to prescription drug price blueprint; direct-to-consumer advertising for prescription drugs; issues related to proposed changes to removal of safe harbor protection for rebates (proposed rule); issues relating to access for investigational drugs; and other issues relating to health care reform implementation.

H.R.2135,"Preventing Adversaries Internationally from Disbursing Advertising Dollars Act or the PAID AD Act," all provisions H.R.2592, Honest Ads Act, all provisions H.R.3327, Drug Price Transparency for Medicare Patients Act of 2019, all provisions H.R.4054,Stand By Every Ad Act, all provisions HR 4106, Responsibility in Drug Advertising Act of 2019, all provisions H.Con.Res.55, Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements, all provisions S.73, "End Taxpayer Subsidies for Drug Ads Act, all provisions related to advertising S.474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019," all provisions related to advertising S.1356, Honest Ads Act, all provisions S.1437, Drug-price Transparency in Communications (DTC) Act, all provisions

Client expense: $900,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

-HR 466 - Amateur Radio Parity Act - all provisions related to cable. -HR 583 - Preventing Illegal Radio Abuse Through Enforcement (PIRATE) Act - all provisions related to cable. -HR 896 - Fairness in Political Advertising Act of 2019 - all provisions related to cable. -HR 1789 - Local and Independent Television Protection Act - all provisions related to cable. -HR 1848 - Communications Jobs Training Act of 2019 - all provisions related to cable. -HR 2135 - Preventing Adversaries Internationally from Disbursing Advertising Dollars (PAID AD) Act - all provisions related to cable. -HR 2592 - Honest Ads Act - all provisions related to cable. -HR 2860 - Bots Research Act - all provisions related to cable. -HR 3002 - To provide for the carriage of certain television broadcast stations - all provisions related to cable. -HR 2682 - Agricultural News and Rural Content Act of 2019 - all provisions related to cable. -HR 3327 - Drug Price Transparency for Medicare Patients Act of 2019 - all provisions related to cable. -HR 3393 - To amend the Communications Act of 1934 to prohibit Federal funding for the Corporation for Public Broadcasting after fiscal year 2021 - all provisions related to cable. -HR 3994 - Modern Television Act of 2019 - all provisions related to cable. -HR 4054 - Stand by Every Ad Act - all provisions related to cable. -HR 4106 - Responsibility in Drug Advertising Act of 2019 - all provisions related to cable. -HRes 549 - Reaffirming the commitment to media diversity and pledging to work with media entities and diverse stakeholders to develop common ground solutions to eliminate barriers to media diversity - all provisions related to cable. -HConRes 20 - Supporting the Local Radio Freedom Act - all provisions related to cable. -HConRes 55 - Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements - all provisions related to cable. -S 822 - To permit the televising of Supreme Court proceedings - all provisions related to cable. -S 941 - Section 331 Obligation Clarification Act - all provisions related to cable. -S 1228 - Preventing Illegal Radio Abuse Through Enforcement (PIRATE) Act - all provisions related to cable. -S 1356 - Honest Ads Act - all provisions related to cable. -S 1748 - Furthering Access and Networks for Sports Act - all provisions related to cable. -S 1962 - Preventing Adversaries Internationally from Disbursing Advertising Dollars (PAID AD) Act - all provisions related to cable. -S 2125 - Bot Disclosure and Accountability Act of 2019 - all provisions related to cable. -S 2181 - Cyber AIR Act - all provisions related to cable. -S 2182 - Security and Privacy in Your Car (SPY Car) Act of 2019 - all provisions related to cable. -S 2454 - Go Pack Go Act of 2019 - all provisions related to cable. -SRes 306 - Reaffirming the commitment to media diversity and pledging to work with media entities and diverse stakeholders to develop common ground solutions to eliminate barriers to media diversity - all provisions related to cable.